Gene · 10280
Papers1,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers. | Front Cell Dev Biol | 2023 | 37645246 | PubTator, text mining | PubMed |
| Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis. | Front Neurosci | 2023 | 37638324 | PubTator, text mining | PubMed |
| Progress in circRNA-Targeted Therapy in Experimental Parkinson's Disease. | Pharmaceutics | 2023 | 37631249 | PubTator, text mining | PubMed |
| Structure-Based Modeling of Sigma 1 Receptor Interactions with Ligands and Cholesterol and Implications for Its Biological Function. | Int J Mol Sci | 2023 | 37629160 | PubTator, text mining | PubMed |
| Potential antidepressant-like effects of N-3 polyunsaturated fatty acids through inhibition of endoplasmic reticulum stress. | Psychopharmacology (Berl) | 2023 | 37612456 | PubTator, text mining | PubMed |
| Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review. | Mol Med | 2023 | 37605113 | PubTator, text mining | PubMed |
| Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review). | Int J Mol Med | 2023 | 37594127 | PubTator, text mining | PubMed |
| The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma. | Open Life Sci | 2023 | 37588995 | PubTator, text mining | PubMed |
| CENPA-driven STMN1 Transcription Inhibits Ferroptosis in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37577230 | PubTator, text mining | PubMed |
| Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands. | Pharmacol Rep | 2023 | 37572216 | PubTator, text mining | PubMed |
| Correlates of Iron, Cobalamin, Folate, and Vitamin A Status among Stunted Children: A Cross-Sectional Study in Uganda. | Nutrients | 2023 | 37571364 | PubTator, text mining | PubMed |
| Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. | Cells | 2023 | 37566027 | PubTator, text mining | PubMed |
| Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration. | J Biomed Sci | 2023 | 37550658 | PubTator, text mining | PubMed |
| Genetic and Neuroimaging Analysis of SIGMAR1 for Frontotemporal Dementia. | J Alzheimers Dis | 2023 | 37545231 | PubTator, text mining | PubMed |
| Ultrastructural analysis of prostate cancer tissue provides insights into androgen-dependent adaptations to membrane contact site establishment. | Front Oncol | 2023 | 37529692 | PubTator, text mining | PubMed |
| The Sigma-1 Receptor Is a Novel Target for Improving Cold Preservation in Rodent Kidney Transplants. | Int J Mol Sci | 2023 | 37511389 | PubTator, text mining | PubMed |
| The 27th Scientific Conference of the Society on NeuroImmune Pharmacology: New Delhi, India, March 15-18, 2023. | NeuroImmune Pharm Ther | 2023 | 37476290 | PubTator, text mining | PubMed |
| The potential of psychedelics for the treatment of Alzheimer's disease and related dementias. | Eur Neuropsychopharmacol | 2023 | 37451163 | PubTator, text mining | PubMed |
| An Emerging Role for Sigma Receptor 1 in Personalized Treatment of Breast Cancer. | Cancers (Basel) | 2023 | 37444574 | PubTator, text mining | PubMed |
| Interleukin 24: Signal Transduction Pathways. | Cancers (Basel) | 2023 | 37444474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10280/papers?page=11